127406-08-0

Basic information

• Product Name: 4-PYRAZIN-2-YLBENZALDEHYDE
• Synonyms: 4-(2-PYRAZINYL)BENZENECARBALDEHYDE;4-PYRAZIN-2-YLBENZALDEHYDE;4-(Pyrazin-2-yl)benzenecarboxaldehyde
• CAS NO: 127406-08-0
• Molecular Formula: C₁₁H₈N₂O
• Molecular Weight: 184.19
• EINECS: 604-604-1
• Mol File: 127406-08-0.mol

Chemical Properties

• Melting Point: 84-87°
• Boiling Point: 347.2±32.0 °C(Predicted)
• Appearance: /
• Density: 1.205±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 0.23±0.10(Predicted)
• CAS DataBase Reference: 4-PYRAZIN-2-YLBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-PYRAZIN-2-YLBENZALDEHYDE(127406-08-0)
• EPA Substance Registry System: 4-PYRAZIN-2-YLBENZALDEHYDE(127406-08-0)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22-36
• Safety Statements: 26
• HazardClass: IRRITANT
• Hazardous Substances Data: 127406-08-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-Pyrazin-2-ylbenzaldehyde is used as a key intermediate in the synthesis of various pharmaceuticals for its versatile chemical properties and potential therapeutic applications.
Used in Organic Chemistry:
4-Pyrazin-2-ylbenzaldehyde is used as a building block in the synthesis of other organic compounds, contributing to the development of new materials and chemical products.
Used in Chemosensing Applications:
The derivative of 4-Pyrazin-2-ylbenzaldehyde, Phenylhydrazone, is used in the practice of chemosensing ensemble for the detection of nerve gases and pesticides, highlighting its potential in environmental and safety monitoring.
Safety Measures:
4-Pyrazin-2-ylbenzaldehyde may pose hazards if improperly handled or used. Therefore, appropriate safety measures should be followed to ensure safe handling and usage in various applications.

Upstream product

• 14508-49-7 2-chloropyrazin 
• 87199-17-5 4-formylphenylboronic acid, 
• 59016-93-2 p-hydroxymethylphenylboronic acid 
• 4009-98-7 (methoxymethyl)triphenylphosphonium chloride 

Downstream Products

• 868856-13-7 C₁₅H₁₄N₂O₂ 
• 216060-23-0 4-(pyrazin-2-yl)benzoic acid 

Relevant articles and documents

Biarylcarboxybenzamide derivatives as potent vanilloid receptor (VR1) antagonistic ligands

Seventeen biarylcarboxybenzamide derivatives were prepared for the study of their agonistic/antagonistic activities to the vanilloid receptor (VR1) in rat DRG neurons. The replacement of the piperazine moiety of the lead compound 1 with phenyl ring showed quite enhanced antagonistic activity. Among the prepared derivatives, N-(4-tert-butylphenyl)-4-pyridine-2-yl-benzamide (2, IC 50 = 31 nM) and N-(4-tert-butylphenyl)-4-(3-methylpyridine-2-yl) benzamide (3g, IC50 = 31 nM), showed 5-fold higher antagonistic activity than 1 in 45Ca2+-influx assay.

Synthesis, crystal structures and catalytic activity of three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with N-heterocyclic carbenes (NHCs) and triphenylphosphine

Three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with NHCs and PPh3 1-3 have been synthesized and characterized by elemental analysis, IR, NMR and single-crystal X-ray diffraction. Their application to Suzuki coupling of phenylboro

A general catalyst for Suzuki-Miyaura and Sonogashira reactions of aryl and heteroaryl chlorides in water

We report the synthesis of 2-(3-sulfonatomesityl)-5-sulfonatoindenyl) dicyclohexylphosphine hydrate sodium salt and its use in palladium-catalyzed Suzuki-Miyaura and Sonogashira coupling reactions in water (and biphasic water-organic solvent mixtures) to prepare a variety of functionalized biaryls and aryl alkynes in excellent yield. This journal is the Partner Organisations 2014.

Synthesis, crystal structures and catalytic activity of three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with N-heterocyclic carbenes (NHCs) and triphenylphosphine

Three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with NHCs and PPh3 1-3 have been synthesized and characterized by elemental analysis, IR, NMR and single-crystal X-ray diffraction. Their application to Suzuki coupling of phenylboronic acid co

Synthesis, crystal structures and catalytic activity of three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with N-heterocyclic carbenes (NHCs) and triphenylphosphine

Three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with NHCs and PPh31-3 have been synthesized and characterized by elemental analysis, IR, NMR and single-crystal X-ray diffraction. Their application to Suzuki coupling of phenylboron

11,12-Cyclic thiocarbamate macrolide antibacterial agents

The present invention is directed to novel macrolide antibacterial agents and processes for preparing them. The present invention is further directed to pharmaceutical compositions containing the novel macrolide antibacterial agents disclosed herein and t

Methods of treatment using an EP2 selective receptor agonist

The present invention relates to methods of treating pulmonary hypertension, facilitating joint fusion, facilitating tendon and ligament repair, reducing the occurrence of secondary fracture, treating avascular necrosis, facilitating cartilage repair, facilitating bone healing after limb transplantation, facilitating liver regeneration, facilitating wound healing, reducing the occurrence of gastric ulceration, treating hypertension, facilitating the growth of tooth enamel or finger or toe nails, treating glaucoma, treating ocular hypertension, and repairing damage caused by metastatic bone disease using an EP2 selective receptor agonist.

3-Descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents

3-Descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents of the formula: wherein R1, W, R3, R4, R5, R6, X, X′, and Z are as described herein and in which the substituents have th

6-O-acyl ketolide antibacterials

6-O-Acyl ketolide antibacterials of the formula: wherein R1, R2, R3, R4, W, X, X′, Y, and Y′ are as described herein and in which the substituents have the meaning indicated in the description. These compounds are useful as antibacterial agents.

Method for treating glaucoma

Methods of using prostaglandin agonists for the reduction of intraocular pressure, and accordingly glaucoma.